|本期目录/Table of Contents|

[1]涂 波,储 芳,许 彪,等.驻西非3 例华人特殊疟疾病例诊疗体会[J].传染病信息,2019,05:466-470.
 TU Bo,CHU Fang,XU Biao,et al.Experience of diagnosis and treatmentfor 3 Chinese patients with special malaria in West Africa[J].Infectious Disease Information,2019,05:466-470.
点击复制

驻西非3 例华人特殊疟疾病例诊疗体会(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2019年05期
页码:
466-470
栏目:
病例报道
出版日期:
2019-11-13

文章信息/Info

Title:
Experience of diagnosis and treatmentfor 3 Chinese patients with special malaria in West Africa
文章编号:
1007-8134(2019)05-0466-06
作者:
涂 波储 芳许 彪田 园左曙青赵光宇郑俊杰陈威巍
100039北京,中国人民解放军总医院第五医学中 心感染性疾病诊疗与研究中心(涂波、陈威巍),青少年肝病 诊疗与研究中心(储芳),重症医学中心(许彪),卫勤 部(郑俊杰);130122长春,军事科学院军事医学研究院军事 兽医研究所流行病学与病原微生物研究室(田园);100071北京, 军事科学院军事医学研究院微生物流行病研究所病原微生物生物 安全国家重点实验室(左曙青、赵光宇) 前两位作者对本文有同等贡献,均为第一作者
Author(s):
TU Bo CHU Fang XU Biao TIAN Yuan ZUO Shu-qing ZHAO Guang-yu ZHENG Jun-jie CHEN Wei-wei*
Treatment and Research Center for Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, ChinaTU Bo and CHU Fang are the first authors who contributed equally to the article
关键词:
疟疾疟原虫西非诊疗体会
Keywords:
malaria plasmodium West Africa diagnosis and treatment experience
分类号:
R531.3
DOI:
10.3969/j.issn.1007-8134.2019.05.021
文献标识码:
A
摘要:
疟疾是对全球健康影响最大的传染病,西非是疟疾的高流行地区。本文通过报道我国援塞拉利昂军事医学专家组在塞拉利昂诊治的 3例疟疾患者的经验和体会,以期为临床医生在诊治类似疾病时提供参考、借鉴。
Abstract:
Malaria is the most serious infectious disease affecting global health. West Africa is a highly prevalent area ofmalaria. This article reports the experience of diagnosis and treatment for 3 Chinese malaria patients in Sierra Leone by Chinese Military Medical Expert Group for Sierra Leone, in order to provide reference for clinicians in diagnosis and treatment of similar disease.

参考文献/References

[1] Komaki-Yasuda K, Vincent JP, Nakatsu M, et al. A novel PCRbased system for the detection of four species of human malaria parasites and Plasmodium knowlesi[J]. PLoS One, 2018, 13(1):e0191886.
[2] World Health Organization. World malaria report 2018[R]. Geneva: WHO, 2018.
[3] Boggild AK, Esposito DH, Kozarsky PE, et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network [J]. Ann Intern Med, 2015, 162(11):757-764.
[4] 汤林华,高琪,余新炳,等. 疟疾的诊断—中华人民共和国 卫生行业标准WS 259-2015[S]. 北京:中华人民共和国国 家卫生和计划生育委员会,2015.
[5] World Health Organization. Guidelines for the treatment of malaria-3rd edition[R]. Geneva: WHO, 2015.
[6] Nguyen HP, Hanson J, Bethell D, et al. A retrospective analysis of the haemodynamic and metabolic effects of fluid resuscitation in Vietnamese adults with severe falciparum malaria[J]. PLoS One, 2011, 6(10):e25523.
[7] Aung NM, Kaung M, Kyi TT, et al. The safety of a conservative fluid replacement strategy in adults hospitalised with malaria[J]. PLoS One, 2015, 10(11):e0143062.
[8] Ishioka H, Plewes K, Pattnaik R, et al. Associations between restrictive fluid management and renal function and tissue perfusion in adults with severe falciparum malaria - a prospective observational study[J]. J Infect Dis, 2019:pii:jiz449.
[9] Jalani HA, Shah SMA, Anjum F, et al. Prevalence and co-infection of malaria and typhoid in the local population of Faisalabad, Pakistan[J]. Pak J Pharm Sci, 2019, 32(Suppl 1):323-326.
[10] Odikamnoro OO, Ikeh IM, Okoh FN, et al. Incidence of malaria/ typhoid co-infection among adult population in Unwana Community, Afikpo North Local Government Area, Ebonyi State, Southeastern Nigeria[J]. Afr J Infect Dis, 2017, 12(1):33-38.
[11] Shaikh QH, Ahmad SM, Abbasi A, et al. Thrombocytopenia in malaria[J]. J Coll Physicians Surg Pak, 2009, 19(11):708-710.
[12] Naing C, Whittaker MA. Severe thrombocytopaenia in patients with vivax malaria compared to falciparum malaria: a systematic review and meta-analysis[J]. Infect Diseases Poverty, 2018, 7(1):10.
[13] Kho S, Barber BE, Johar E, et al. Platelets kill circulating parasites of all major plasmodium species in human malaria[J]. Blood, 2018, 132(12):1332-1344.
[14] Lampah DA, Yeo TW, Malloy M, et al. Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia[J]. J Infect Dis, 2015, 211(4):623-634.
[15] 邹洋,冯曼玲,王非,等. 150 例疟疾患者救治临床分析[J]. 传染病信息,2012,25(1):26-28.
[16] Groger M, Fischer HS, Veletzky L, et al. A systematic review of the clinical presentation, treatment and relapse characteristics of human Plasmodium ovale malaria[J]. Malar J, 2017, 16(1):112.
[17] 王磊,王非,齐志群,等. 62例输入性疟疾病原学特点分析[J]. 传染病信息,2016,29(3):170-172.
[18] Watson OJ, Sumner KM, Janko M, et al. False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa[J]. BMJ Glob Health, 2019, 4(4):e001582.
[19] 李冉,王康椿,叶青. 镜检法与金标法在疟原虫筛查中的应 用[J]. 实验与检验医学,2018,36(5):710-711,758.
[20] 唐凤,唐建霞,陆凤. 万孚疟原虫检测试剂盒检测卵形疟原 虫效果评价及影响因素分析[J]. 中国血吸虫病防治杂志, 2016,28(2):146-150.
[21] Gama BE, Silva-Pires Fdo E, Lopes MN, et al. Real-time PCR versus conventional PCR for malaria parasite detection in lowgrade parasitemia[J]. Exp Parasitol, 2007, 116(4):427-432.
[22] 王冶,刘昊,黎檀实,等. 蒿甲醚和双氢青蒿素治疗维和部 队疟疾93 例分析[J]. 传染病信息,2007,20(1):42-44.
[23] Ataide R, Ashley EA, Powell R, et al. Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort[J]. Proc Nati Acad Sci U S A, 2017, 114(13):3515-3520.
[24] Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria[J]. Lancet, 2018, 391(10130):1608-1621.
[25] 高琪. 《抗疟药物使用规范》的解读[J]. 中国寄生虫学与 寄生虫病杂志,2017,35(4):1-4.
[26] Hamilton WL, Amato R, van der Pluijm RW, et al. Evolution and expansion of multidrug-resistant malaria in Southeast Asia:a genomic epidemiology study[J]. Lancet Infect Dis, 2019, 19(9):943-951.

备注/Memo

备注/Memo:
[基金项目]国家科技重大专项(2018ZX10101003-001-007)
[作者单位]100039北京,中国人民解放军总医院第五医学中 心感染性疾病诊疗与研究中心(涂波、陈威巍),青少年肝病 诊疗与研究中心(储芳),重症医学中心(许彪),卫勤 部(郑俊杰);130122长春,军事科学院军事医学研究院军事 兽医研究所流行病学与病原微生物研究室(田园);100071北京, 军事科学院军事医学研究院微生物流行病研究所病原微生物生物 安全国家重点实验室(左曙青、赵光宇) 前两位作者对本文有同等贡献,均为第一作者
[通信作者]陈威巍,E-mail:cww302@126.com
*Correspondingauthor,E-mail:cww302@126.com
更新日期/Last Update: 2019-11-13